Insider filing · CGON
Hong Fang Song sold $19.6M of CG Oncology (CGON)
Executed Dec 16 2024, disclosed Dec 17 2024, 1 day later.
Value, as filed
$19.6M
700,000 sh × $28.00
Executed
Dec 16 2024
the trade date, as filed
Disclosed
Dec 17 2024
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HS
Hong Fang Song
Director
profile →
Hong Fang Song (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in CG Oncology, Inc. (CGON). The largest single filing was $19.6M of CGON (700,000 sh × $28.00, as filed), executed Dec 16 2024.
The name
CGON
CG Oncology, Inc.
CGON · Healthcare · 14 filings in 24 months
ticker →
Healthcare · CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Hong Fang Song in CGON
CGONSALE
CG Oncology, Inc.
$2.8M99,800 sh across 2 lots
Exec Sep 3 2025
Filed Sep 4 2025 · 5:30 PM ET